The Onset of In-Vivo Dehydration in Gas -Based Intraperitoneal Hyperthermia and Its Cytotoxic Effects on Colon Cancer Cells
Copyright © 2022 Diakun, Khosrawipour, Mikolajczyk-Martinez, Nicpoń, Kiełbowicz, Prządka, Liszka, Kielan, Zielinski, Migdal, Lau, Li and Khosrawipour..
Background: Peritoneal metastasis (PM) is an ongoing challenge in surgical oncology. Current therapeutic options, including intravenous and intraperitoneal (i.p.) chemotherapies display limited clinical efficacy, resulting in an overall poor prognosis in affected patients. Combined hyperthermia and dehydration induced by a high-flow, gas-based i.p. hyperthermic procedure could be a novel approach in PM treatment. Our study is the first to evaluate the therapeutic potential of i.p. dehydration, hyperthermia, as well as the combination of both mechanisms in an in-vivo setting.
Methods: For this study, three swine were subjected to diagnostic laparoscopy under a high-flow air stream at 48°, 49° and 50°Celsius (C). Hygrometry of the in- and outflow airstream was measured to calculate surface evaporation and i.p. dehydration. To analyze the effects of this concept, in vitro colon cancer cells (HT-29) were treated with hyperthermia and dehydration. Cytotoxicity and cell viability were measured at different time intervals. Additionally, structural changes of dehydrated cells were analyzed using scanning electron microscopy.
Results: According to our results, both dehydration and hyperthermia were cytotoxic to HT-29 cells. However, while dehydration reduced cell viability, hyperthermia did not. However, dehydration effects on cell viability were significantly increased when combined with hyperthermia (p<0.01).
Conclusions: Changes to the physiological milieu of the peritoneal cavity could significantly reduce PM. Therefore, limited dehydration of the abdominal cavity might be a feasible, additional tool in PM treatment. Further studies are required to investigate dehydration effects and their applicability in PM management.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
Frontiers in oncology - 12(2022) vom: 16., Seite 927714 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Diakun, Agata [VerfasserIn] |
---|
Links: |
---|
Themen: |
Colorectal cancer |
---|
Anmerkungen: |
Date Revised 19.07.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3389/fonc.2022.927714 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM343681366 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM343681366 | ||
003 | DE-627 | ||
005 | 20231226205010.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3389/fonc.2022.927714 |2 doi | |
028 | 5 | 2 | |a pubmed24n1145.xml |
035 | |a (DE-627)NLM343681366 | ||
035 | |a (NLM)35847916 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Diakun, Agata |e verfasserin |4 aut | |
245 | 1 | 4 | |a The Onset of In-Vivo Dehydration in Gas -Based Intraperitoneal Hyperthermia and Its Cytotoxic Effects on Colon Cancer Cells |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 19.07.2022 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright © 2022 Diakun, Khosrawipour, Mikolajczyk-Martinez, Nicpoń, Kiełbowicz, Prządka, Liszka, Kielan, Zielinski, Migdal, Lau, Li and Khosrawipour. | ||
520 | |a Background: Peritoneal metastasis (PM) is an ongoing challenge in surgical oncology. Current therapeutic options, including intravenous and intraperitoneal (i.p.) chemotherapies display limited clinical efficacy, resulting in an overall poor prognosis in affected patients. Combined hyperthermia and dehydration induced by a high-flow, gas-based i.p. hyperthermic procedure could be a novel approach in PM treatment. Our study is the first to evaluate the therapeutic potential of i.p. dehydration, hyperthermia, as well as the combination of both mechanisms in an in-vivo setting | ||
520 | |a Methods: For this study, three swine were subjected to diagnostic laparoscopy under a high-flow air stream at 48°, 49° and 50°Celsius (C). Hygrometry of the in- and outflow airstream was measured to calculate surface evaporation and i.p. dehydration. To analyze the effects of this concept, in vitro colon cancer cells (HT-29) were treated with hyperthermia and dehydration. Cytotoxicity and cell viability were measured at different time intervals. Additionally, structural changes of dehydrated cells were analyzed using scanning electron microscopy | ||
520 | |a Results: According to our results, both dehydration and hyperthermia were cytotoxic to HT-29 cells. However, while dehydration reduced cell viability, hyperthermia did not. However, dehydration effects on cell viability were significantly increased when combined with hyperthermia (p<0.01) | ||
520 | |a Conclusions: Changes to the physiological milieu of the peritoneal cavity could significantly reduce PM. Therefore, limited dehydration of the abdominal cavity might be a feasible, additional tool in PM treatment. Further studies are required to investigate dehydration effects and their applicability in PM management | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a colorectal cancer | |
650 | 4 | |a dehydration | |
650 | 4 | |a electron microscopy | |
650 | 4 | |a hyperthermia | |
650 | 4 | |a peritoneal metastasis (PM) | |
700 | 1 | |a Khosrawipour, Tanja |e verfasserin |4 aut | |
700 | 1 | |a Mikolajczyk-Martinez, Agata |e verfasserin |4 aut | |
700 | 1 | |a Nicpoń, Jakub |e verfasserin |4 aut | |
700 | 1 | |a Kiełbowicz, Zdzisław |e verfasserin |4 aut | |
700 | 1 | |a Prządka, Przemysław |e verfasserin |4 aut | |
700 | 1 | |a Liszka, Bartłomiej |e verfasserin |4 aut | |
700 | 1 | |a Kielan, Wojciech |e verfasserin |4 aut | |
700 | 1 | |a Zielinski, Kacper |e verfasserin |4 aut | |
700 | 1 | |a Migdal, Pawel |e verfasserin |4 aut | |
700 | 1 | |a Lau, Hien |e verfasserin |4 aut | |
700 | 1 | |a Li, Shiri |e verfasserin |4 aut | |
700 | 1 | |a Khosrawipour, Veria |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Frontiers in oncology |d 2011 |g 12(2022) vom: 16., Seite 927714 |w (DE-627)NLM218189583 |x 2234-943X |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2022 |g day:16 |g pages:927714 |
856 | 4 | 0 | |u http://dx.doi.org/10.3389/fonc.2022.927714 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 12 |j 2022 |b 16 |h 927714 |